Company profilePharmaceutical#874 of 1,318 in Pakistan✓ No DRAP alerts

ORGANIC PHARMACEUTICALS.

Pharmaceutical company · 7 brands · 14 molecules

Ranked #53 of 79 companies in Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives

7 registered products 12 pharmaceutical brands 14 distinct molecules 0 DRAP alerts

Company overview

7
registered products
12
pharmaceutical brands
14
distinct molecules
3
therapeutic classes
0
DRAP alerts

ORGANIC PHARMACEUTICALS. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 7 product registrations across 14 distinct molecules. Its portfolio is concentrated in Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives and Antidepressants. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by ORGANIC

4 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Olanzapine1 brand
Trazodone1 brand
Paroxetine1 brand
Risperidone ...... 0.5 Mg1 brand
Risperidone..............1Mg1 brand
Risperidone ...... 2 Mg1 brand
Risperidone ...... 4 Mg1 brand
Risperidone..............3Mg1 brand

Therapeutic classes

Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 2Antidepressants · 1Anti-Infectives · 1

Conditions treated

General Infections · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official9 products · Rs 237.88 – Rs 773.12
DVAGO11 products · Rs 175.8 – Rs 468.4
Servaid2 products · Rs 316.3 – Rs 341.04
Median across source: Rs 331.9

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Amarant Pharmaceuticals Private Limited holds 102 molecules not in this portfolio
AmlodipineAprepitantArtemetherAzithromycinBupropionCefixime
Wilshire Laboratories (Private) Limited holds 132 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin
Genetics Pharmaceuticals Pvt. Ltd holds 70 molecules not in this portfolio
AtomoxetineAtorvastatinAzithromycinBetahistineCarbidopaCefixime

Get the full profile for ORGANIC

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.